1Houghton LA,Atkinson W,Lockhart S.et al.Sigmoid-colonic motility in health and irritable bowel syndrome: a role for 5 hydroxytryptamine[J]. neurogastroenterol Motil, 2007,19:(9) : 724-731.
2Atkinson W.Lockhart S.Whorwell PJ,et a l. Ahered 5-hydroxytryptamine signaling in palients with constipation and diarrhea predominant irritable bowel syndrome[J].Gastroenterology,2006,130(1):34-43.
1Thompson WG, Longstreth GF, Drossman DA, et al. Functional bowel disorders and functional abdominal pain [J]. Gut, 1999(Suppl Ⅱ): Ⅱ44.
2Sjolund K, Ekmon R, lindgren S, et al. Disturbed motilin and cholecystokinin release in the irritable bowel syndrome[J]. Scand J Gastroenterol, 1996,31(11):1l10-1114,.
3Chev WY, Jin HO, Lee MH, et al. Colonic motilitv abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea[J] . Am J Gastroenterology, 2001, 96(5): 1499 - 1506.
4Evangelista S. Involvement of tachyklnin in intestinal inflammation[J]. Curt Pharm Des, 2001, 7( 1 ): 19 - 30.
5Camilleri M. Ford M J, Review article: colonic sensorimotor physiology in health, and its alteration in constipation and diarrhoeal disorders[J]. Aliment Pharmacol Ther,1998,12(4): 287 - 302.
6Chiba T, Park J, Kadowaki S, et aL Glueagon and vasoacrive intestinal polypeptide stimulate somatostatin from isolated canine fundic mueosal cell culture [J]. Gastroenterology, 1985, 88: 1384(A).
7Yehuda Ringel, Ami D Sperber, Douglas A Dross man. Irritable bowel syndrome[J] , Annu Rev Med, 2001, 52:319 -338.
